Expand+Candidates must have obtained at least an upper Second Class Honours (2:1) Grade or equivalent in an honours BSc in Biotechnology, Biochemistry, Microbiology, Genetics, Neuroscience, Physiology, Pharmacology, Medicinal Chemistry or an equivalent qual...

Hide-Candidates must have obtained at least an upper Second Class Honours (2:1) Grade or equivalent in an honours BSc in Biotechnology, Biochemistry, Microbiology, Genetics, Neuroscience, Physiology, Pharmacology, Medicinal Chemistry or an equivalent qualification.

If English is not your native language, unless you have done your primary degree through English in an English speaking country, an English language qualification is required for all programmes. English Language qualifications include a minimum score of 550 (213 computer based) for Test of English as a Foreign Language (TOEFL), or 6.5 (with a score of 6 obtained in each category) for International English Language Testing System (IELTS). Other evidence of proficiency in English may be accepted such as the Cambridge Certificate. Tests used as evidence of language proficiency must have been completed within the last 12 months.

2 academic references will be required, at least one to be from a science faculty member.

Expand+MSc Biotherapeutics and Business
Graduate Taught (level 9 nfq, credits 90)
The MSc in Biotherapeutics and Business educates students on the practical uses of molecular advances in the discovery and of protein and other biomolecular drug candidates ...

Hide-MSc Biotherapeutics and Business
Graduate Taught (level 9 nfq, credits 90)
The MSc in Biotherapeutics and Business educates students on the practical uses of molecular advances in the discovery and of protein and other biomolecular drug candidates and their development into biotherapeutics 

- The UCD MSc Biotherapeutics and Business programme has a global, multidisciplinary perspective with contributions from national and international academics and experts.

- Students share their firsthand practical experience with other MSc students and professionals from a diverse range of countries and backgrounds and this creates a dynamic learning environment.

Course Description
This programme will provide students with a comprehensive understanding of the development of biotherapeutics, beginning with pre-clinical modelling and target identification together with antibody engineering, biochemical and biophysical characterisation and development issues for bioprocessing. Systems biology of biotechnological processes and approaches to the analysis of proteomics based discovery data will be covered in detail together with mathematical modelling, bioinformatics analysis and data integration strategies. Regulatory issues and innovation and commercialisation strategies will also be covered. Mammalian cell culture and bioprocess laboratory structure will be comprehensively covered in addition to novel approaches to therapeutic development. You will also receive a comprehensive business education. You will learn to identify and solve business problems in local and international settings, enhance your communication and leadership skills and improve your ability for independent thinking and developing creative solutions.

The MSc in Biotherapeutics and Business is the result of close collaboration between UCD School of Biomolecular and Biomedical Science and UCD Smurfit School of Business.

Expand+This is a full-time, one-year programme, divided into three semesters (from early September until the end of August). The programme consists of lectures, tutorials, seminars, workshops and case studies. To complete the MSc in Biotherapeutics and Busi...

Hide-This is a full-time, one-year programme, divided into three semesters (from early September until the end of August). The programme consists of lectures, tutorials, seminars, workshops and case studies. To complete the MSc in Biotherapeutics and Business you must successfully complete all core modules and your chosen option modules. You must also successfully complete a business plan and biotherapeutics case study.

Stage 1 - Core
Professional Career Development
BIOC40180
Mgt & Org Behav MSc Bio&B
BMGT45050
The Business of Biotechnology and Science
BMOL40120
Corporate Finance (BB)
FIN41440
Marketing Management MSc Bio&B
MKT42310
Biotherapeutic Pipeline I
PHAR40200
Biotherapeutic Pipeline II
PHAR40210
Systems Biology in Drug Dev
PHAR40220
Valuation & Commercialisation of Biotherapeutics
PHAR40250
Biotherapeutics Case Study
PHAR40260

Stage 1 - Option
Biomedical Diagnostics
BIOC40110
Pharmacology and Drug Development
BIOC40170
Biological Imaging
BMOL40180
Multicellular Systems
BMOL40190
HCS Microscopy
CELB40160
Bioprocessing Laboratory
CHEN40090
Recombinant DNA Technology
MICR40010
Emerging Issues in Biotechnology
MICR40100
Regulatory Affairs in Science
PHAR40240

Expand+Career Opportunities
This advanced graduate degree in Biotherapeutics and Business has been developed in consultation with employers and therefore will be recognised and valued by them. A key feature is the opportunity to carry out a busines...

Hide-Career Opportunities
This advanced graduate degree in Biotherapeutics and Business has been developed in consultation with employers and therefore will be recognised and valued by them. A key feature is the opportunity to carry out a business development plan which will allow graduates to develop connections with prospective employers, thereby enhancing chances of employment on graduation.

Prospective employers include: Abbott; Allergan; Amgen; Baxter Healthcare; Eli Lilly and Co.; Dignity Sciences; Glaxo SmithKline; Icon Clinical Research; ImmunoGen Inc.; Janssen Pharmaceutical Ltd.; Johnson & Johnson Ltd.; Merck Sharp & Dohme; Quintiles; Quest International; Sandoz; Seroba Kernel.

Related Programmes
MSc Biotherapeutics FT
F102,X447,X439,F104